ArticleSensors (Basel, Switzerland)2025
Design and Testing of an Emg-Controlled Semi-Active Knee Prosthesis.
Article in Sensors (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development and Biomechanical Evaluation of a Modular Knee Prosthesis: From Conceptual V1 Design to an Improved V3 Model.Bioengineering (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Affordable, sensor-driven lower-limb prostheses remain scarce in middle-income health systems. We report the design, numerical justification, and bench validation of a semi-active transfemoral prosthesis featuring surface electromyography (EMG) control and inertial sensing for low-resource deployment. The mechanical architecture combines a titanium-aluminum-carbon composite frame (total mass 0.87 kg; parts cost < USD 400) with topology optimization (SIMP) to minimize weight while preserving stiffness. Finite-element analyses (critical load 2.94 kN) confirmed structural safety (yield safety factor ≥ 1.6) and favorable fatigue margins. A dual-channel sensing scheme-surface EMG from the rectus femoris and an IMU-drives a five-state gait finite state machine implemented on a low-power STM32H platform. The end-to-end EMG→PWM latency remained <200 ms (mean 185 ms). Bench tests reproduced commanded flexion within ±2.2%, with average electrical power of ~4.6 W and battery autonomy of ~5.7 h using a 1650 mAh Li-Po pack. Results demonstrate a pragmatic trade-off between functionality and cost: semi-active damping with EMG-triggered control and open, modular hardware suitable for small-lab fabrication. Meeting target metrics (mass ≤ 1 kg, latency ≤ 200 ms, autonomy ≥ 6 h, cost ≤ USD 500), the prototype indicates a viable pathway to broaden access to intelligent prostheses and provides a platform for future upgrades (e.g., neural network control and higher-efficiency actuators).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.